YU20097A - Fluorovani analozi vitamina d3, intermedijeri za njihovo dobijanje, postupak za dobijanje takvih fluorovanih analoga vitamina d3, farmaceutska smeša koja sadrži analoge fluorovanog vitamina d3 i upotreba takvih analoga u proizvodnji farmaceutske smeše za lečenje osteoporoze - Google Patents
Fluorovani analozi vitamina d3, intermedijeri za njihovo dobijanje, postupak za dobijanje takvih fluorovanih analoga vitamina d3, farmaceutska smeša koja sadrži analoge fluorovanog vitamina d3 i upotreba takvih analoga u proizvodnji farmaceutske smeše za lečenje osteoporozeInfo
- Publication number
- YU20097A YU20097A YU20097A YU20097A YU20097A YU 20097 A YU20097 A YU 20097A YU 20097 A YU20097 A YU 20097A YU 20097 A YU20097 A YU 20097A YU 20097 A YU20097 A YU 20097A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- analogues
- vitamin
- preparation
- fluorinated
- hydrogen
- Prior art date
Links
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title abstract 3
- 208000001132 Osteoporosis Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical class O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 title 1
- 230000035876 healing Effects 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 13
- 239000001257 hydrogen Substances 0.000 abstract 9
- 150000002431 hydrogen Chemical group 0.000 abstract 7
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 2
- 125000006763 (C3-C9) cycloalkyl group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Movi fluorovani analozi vitamina D3 formule u kojoj oznacavaju X (H, H) ili =CH2, R1 i R2, nezavisno jedan od drugog, vodonik, (C1-C4)-alkil ili -fluoralkil, ili R1 i R2 zajedno sa C-20 formiraju (C3-C6)-cikloalkil ili -ciklofluoralkil, ili R1 i R2 zajedno formiraju =CH2, R3 i R4, nezavisno jedan od drugog, (C1-C4)-alkil ili fluoralkil, ili R3 i R4 zajedno sa C-25 formiraju (C3-C9)-cikloalkil ili -ciklofluoralkil, A prostu ili dvostruku vezu, i B dvostruku ili trostruku vezu, osim (i) kada X oznacava =CH2, R3 i R4 su svaki CF3, A je dvostruka veza i jedan od R1 ili R2 je vodonik, tada drugi od R1 ili R2 ne moze biti CH3, (ii) kada X oznacava =CH2, R3 i R4 su svaki (C1-C2)-alkil, A je dvostruka veza i R2 je vodonik, tada R1 ne moze biti CH3, (iii) kada X oznacava =CH2, R3 i R4 su svaki (C1-C4)-alkil, A je dvostruka veza i R1 je vodonik, tada R2 ne moze biti CH3, (iv) kada X oznacava =CH2, jedan od R3 ili R4 je CF3, A je dvostruka veza, R1 je CH3 i R2 je vodonik, tada drugi od R3 ili R4 ne moze biti CH3, i (v) kada je X vodonik, R3 i R4 su svaki CF3, A je dvostruka veza, B je trostruka veza i R2 je vodonik, tada R1 ne moze biti CH3, i jedinjenja gore date formule I u kojoj X je (H, H) ili =CH2, R1 i R2 su, nezavisno jedan od drugog, vodonik, (C1-C4)-alkil ili -fluoralkil, ili R1 i R2 zajedno sa C-20 formiraju (C3-C6)-cikloalkil ili -ciklofluoralkil, ili R1 i R2 zajedno formiraju =CH2, R3 i R4 su, nezavisno jedan od drugog, (C1-C4)-alkil ili -fluoralkil, ili R3 i R4 zajedno sa C-25 formiraju (C3-C9)-cikloalkil ili -ciklofluoralkil, A je prosta ili dvostruka veza, i B je dvostruka ili trostruka veza, osim kada su R3 i R4 svaki CF3 i A je dvostruka veza i B je trostruka veza i R2 je vodonik, tada R1 ne moze biti CH3, se koriste u lecenju osteoporoze.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1821996P | 1996-05-23 | 1996-05-23 | |
| US3990197P | 1997-03-19 | 1997-03-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU20097A true YU20097A (sh) | 1999-09-27 |
Family
ID=26690870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU20097A YU20097A (sh) | 1996-05-23 | 1997-05-20 | Fluorovani analozi vitamina d3, intermedijeri za njihovo dobijanje, postupak za dobijanje takvih fluorovanih analoga vitamina d3, farmaceutska smeša koja sadrži analoge fluorovanog vitamina d3 i upotreba takvih analoga u proizvodnji farmaceutske smeše za lečenje osteoporoze |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0808832B1 (sh) |
| JP (1) | JP2859248B2 (sh) |
| KR (1) | KR100253961B1 (sh) |
| CN (1) | CN100402497C (sh) |
| AR (1) | AR007776A1 (sh) |
| AT (1) | ATE238278T1 (sh) |
| AU (1) | AU733970B2 (sh) |
| BR (1) | BR9703385A (sh) |
| CA (1) | CA2205315C (sh) |
| CO (1) | CO4940503A1 (sh) |
| CZ (1) | CZ157797A3 (sh) |
| DE (1) | DE69721123T2 (sh) |
| DK (1) | DK0808832T3 (sh) |
| ES (1) | ES2195049T3 (sh) |
| HR (1) | HRP970272A2 (sh) |
| HU (1) | HUP9700928A3 (sh) |
| IL (1) | IL120844A0 (sh) |
| MA (1) | MA24250A1 (sh) |
| NO (1) | NO972278L (sh) |
| NZ (1) | NZ314840A (sh) |
| PE (1) | PE66798A1 (sh) |
| PL (1) | PL320130A1 (sh) |
| PT (1) | PT808832E (sh) |
| SG (1) | SG70010A1 (sh) |
| TR (1) | TR199700416A2 (sh) |
| YU (1) | YU20097A (sh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008209A (en) * | 1997-04-28 | 1999-12-28 | Hoffmann-La Roche Inc. | Method of using vitamin D3 analogs with bis C-20 side chains |
| DE19935771A1 (de) | 1999-07-23 | 2001-02-01 | Schering Ag | Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| WO2002013832A1 (fr) * | 2000-08-17 | 2002-02-21 | Chugai Seiyaku Kabushiki Kaisha | Agent therapeutique destine au traitement de l'osteoporose |
| CA2459789A1 (en) * | 2001-09-21 | 2003-04-03 | F. Hoffmann-La Roche Ag | 3-desoxy-vitamin d3 analog esters |
| US7332482B2 (en) | 2003-09-24 | 2008-02-19 | Bioxell S.P.A. | Method for treating benign prostatic hyperplasia |
| JP2008514621A (ja) * | 2004-09-24 | 2008-05-08 | ビオクセル エッセ ピ ア | ２０−シクロアルキル，２６，２７−アルキル／ハロアルキル−ビタミンｄ３化合物及びその使用方法 |
| US20090099140A1 (en) * | 2005-03-23 | 2009-04-16 | Bioxell S.P.A. | 20-Alkyl, Gemini Vitamin D3 Compounds and Methods of Use Thereof |
| BR112013009647A2 (pt) | 2010-10-25 | 2016-07-12 | Teijin Pharma Ltd | derivado de vitamina, composição farmacêutica, agente terapêutico, e, composto |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4141746A1 (de) * | 1991-12-13 | 1993-06-17 | Schering Ag | 20-methyl-substituierte vitamin d-derivate |
| DE4220757A1 (de) * | 1992-06-24 | 1994-01-05 | Schering Ag | Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
| US5428029A (en) * | 1993-11-24 | 1995-06-27 | Hoffmann-La Roche Inc. | Vitamin D3 fluorinated analogs |
| US5384314B1 (en) * | 1994-03-11 | 1997-08-05 | Hoffmann La Roche | 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol |
| WO1997016193A1 (en) * | 1995-10-27 | 1997-05-09 | F. Hoffmann-La Roche Ag | Pharmaceutical composition for treating osteoporosis |
-
1997
- 1997-05-12 SG SG1997001484A patent/SG70010A1/en unknown
- 1997-05-14 EP EP97107868A patent/EP0808832B1/en not_active Expired - Lifetime
- 1997-05-14 CA CA002205315A patent/CA2205315C/en not_active Expired - Fee Related
- 1997-05-14 DK DK97107868T patent/DK0808832T3/da active
- 1997-05-14 DE DE69721123T patent/DE69721123T2/de not_active Expired - Lifetime
- 1997-05-14 AT AT97107868T patent/ATE238278T1/de not_active IP Right Cessation
- 1997-05-14 ES ES97107868T patent/ES2195049T3/es not_active Expired - Lifetime
- 1997-05-14 PT PT97107868T patent/PT808832E/pt unknown
- 1997-05-16 IL IL12084497A patent/IL120844A0/xx unknown
- 1997-05-16 PE PE1997000387A patent/PE66798A1/es not_active Application Discontinuation
- 1997-05-16 NZ NZ314840A patent/NZ314840A/en unknown
- 1997-05-20 NO NO972278A patent/NO972278L/no unknown
- 1997-05-20 YU YU20097A patent/YU20097A/sh unknown
- 1997-05-20 HR HR60/039,901A patent/HRP970272A2/xx not_active Application Discontinuation
- 1997-05-21 HU HU9700928A patent/HUP9700928A3/hu unknown
- 1997-05-21 MA MA24631A patent/MA24250A1/fr unknown
- 1997-05-21 AR ARP970102159A patent/AR007776A1/es active IP Right Grant
- 1997-05-22 KR KR1019970020029A patent/KR100253961B1/ko not_active IP Right Cessation
- 1997-05-22 JP JP9131810A patent/JP2859248B2/ja not_active Expired - Fee Related
- 1997-05-22 AU AU23576/97A patent/AU733970B2/en not_active Ceased
- 1997-05-22 CN CNB971134324A patent/CN100402497C/zh not_active Expired - Fee Related
- 1997-05-22 CZ CZ971577A patent/CZ157797A3/cs unknown
- 1997-05-22 PL PL97320130A patent/PL320130A1/xx unknown
- 1997-05-22 CO CO97028096A patent/CO4940503A1/es unknown
- 1997-05-23 BR BR9703385A patent/BR9703385A/pt not_active Application Discontinuation
- 1997-05-23 TR TR97/00416A patent/TR199700416A2/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR890011837A (ko) | 디데하이드로 비타민 d₃유도체 | |
| ES2114646T3 (es) | Procedimiento para la produccion de una composicion de recubrimiento de polvo. | |
| YU20197A (sh) | Analozi vitamina d3, farmaceutske kompozicije koje ih sadrže kao aktivnu materiju i njihova upotreba u proizvodnji farmaceutskih kompozicija | |
| KR900006318A (ko) | 피페리디닐 벤즈이미다졸 | |
| ATE36699T1 (de) | Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung. | |
| ES479272A1 (es) | Un procedimiento para la preparacion de esteres de acidos 17beta-tiocarboxilicos de 4-halo-3-oxoandrost-4-enos. | |
| YU20097A (sh) | Fluorovani analozi vitamina d3, intermedijeri za njihovo dobijanje, postupak za dobijanje takvih fluorovanih analoga vitamina d3, farmaceutska smeša koja sadrži analoge fluorovanog vitamina d3 i upotreba takvih analoga u proizvodnji farmaceutske smeše za lečenje osteoporoze | |
| DK0414529T3 (da) | Substituerede steroidderivater | |
| MY117090A (en) | Substituted benzamidines, their preparation and their use as pharmaceutical compounds | |
| ES8303395A1 (es) | "procedimiento de preparar compuestos benzoxepinicos y analogos". | |
| AR007240A1 (es) | Analogos de vitamina d3 fluorados, mezclas y composiciones farmaceuticas que los contienen y su empleo para elaborar una composicion farmaceutica | |
| ES8701761A1 (es) | Un procedimiento para la preparacion de derivados de podofilotoxina. | |
| DE3576346D1 (de) | N6-acenaphthyl-adenosine und analoga davon. | |
| ES8506575A1 (es) | Procedimiento para la preparacion de nuevos derivados de acidos fenilalcanoicos. | |
| ATE40997T1 (de) | 1,5-benzothiazepin-derivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen sowie ihre verwendung. | |
| DE69806152D1 (de) | Vitamin d3 analoga mit bis-c-20-seitenketten | |
| HK1023346A1 (en) | Novel substituted tetrahyropyridine derivatives, method of preparation and pharmaceutical compositions containing them | |
| MX9307203A (es) | COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS. | |
| AU586477B2 (en) | Hexenoic acids | |
| DE69132050D1 (de) | Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung | |
| ES2038612T3 (es) | Compuestos de hidroquinolina, composiciones que los contienen y procedimientos para prepararlas. | |
| YU10397A (sh) | Derivati 1,25-dihidroksi-16,22,23-trisdehidro -holekalciferola postupak za njihovu proizvodnju, njihovo korišćenje i farmaceutske smeše koje ih sadrže | |
| US3989736A (en) | Prostaglandin 5-indanyl esters | |
| JPS5675486A (en) | Production of novel vinyl sulfide | |
| ECSP972132A (es) | Analogos de vitamina d3 fluorinados (caso ran 4212/74) |